Vaccitech rises as brokerages assign top rating

Barinthus Biotherapeutics

25/05/2021 13:40

** Shares of pharma company  VACC.O  rise 2.3% premarket to
$14.65
    ** At least two brokerages start coverage with top rating on
stock
    ** Jefferies cheers co's broad pipeline of vaccine
therapies, especially VTP-200 - co's immunotherapy for high-risk
human papillomavirus infection, as well as revenues from
manufacture and distribution of AstraZeneca's  AZN.L  COVID-19
vaccine 
    ** Shares set to snap a four-day losing streak; up ~5% since
debuting earlier this month

 (Reporting by Susan Mathew in Bengaluru;)
 ((susan.mathew@thomsonreuters.com; +91-80-6287-2704;))